IL-4 and IL-6 have been used to stimulate the differentiation of CD163+ M2-like TAMs from primary human monocytes, and conditioned media from these resulting TAMs increased HNC tumor cell migration, invasion, and angiogenesis in vitro [12]. The gene discussed is IL6; the disease is neoplasm.